Diabetes Experts call this a slight risk
Weeks 9 through 12: 1.0 mg semaglutide per week
found no improvements in bone strength or microarchitecture with liraglutide, suggesting that the effects of GLP-1 receptor agonists on bone remodeling may be context-dependent and influenced by metabolic conditions
To put it another way, Long COVID is associated with immune-inflammatory processes and decreased ANTIOX, while a subgroup of Long COVID patients additionally exhibits increased NO production, oxidative damage to proteins (PCs) and lipids with increased aldehyde formation (MDA), and an immune-oxidative stress response (increased MPO and CRP)
Natalie Hernandez , the program combines advanced pediatric endocrinology with evidence-based nutrition, movement coaching, behavioral support, hormone evaluation, and medicationsincluding GLP-1 therapieswhen medically appropriate
Once treatment stops, weight regain is common (Garvey et al., 2022)